RATIO-NYSTATIN 100000 UNIT
NYSTATIN : 100000 UNIT · DIN 02194236 · TEVA CANADA LIMITED
Health Canada status: CANCELLED POST MARKET
What is RATIO-NYSTATIN?
RATIO-NYSTATIN 100000 UNIT contains NYSTATIN : 100000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02194236, held by TEVA CANADA LIMITED, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is RATIO-NYSTATIN called?
The same molecule, NYSTATIN, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Nilstat | Latin | Australia |
| Mycostatin | Latin | South Africa |
| RIANEST | Latin | Bahrain, Saudi Arabia |
| Candacide Oral Suspension | Latin | South Africa |
| Dermacom | Latin | Saudi Arabia |
| MIKOSTAT | Latin | Bahrain |
| Nystatin Orifarm | Latin | Norway, Sweden |
| Nystimex | Latin | Norway, Sweden |
| ULTRADERM | Latin | Saudi Arabia |
| Canstat Suspension | Latin | South Africa |
| Canstat Topical | Latin | South Africa |
| MYCOSAT | Latin | United Arab Emirates |
| Mycostatin Oral Drops | Latin | Australia |
| Nystacid | Latin | South Africa |
| Nystacid Oral Suspension | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02194236 |
|---|---|
| Brand name | RATIO-NYSTATIN |
| Generic / active ingredient | NYSTATIN : 100000 UNIT |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 100000 UNIT |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AA01 NYSTATIN |
| AHFS class | 84:04.08.28 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jul-2021 |
| Original market date | 1996-09-12 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02194236 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2194236 |
| Brand name | RATIO-NYSTATIN |
| Active ingredient / INN | NYSTATIN : 100000 UNIT |
| ATC code | D01AA01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D01 |
| AHFS class | 84:04.08.28 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | TEVA CANADA LIMITED |
Which pack is which?
| Strength on the label | 100000 UNIT |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code D01AA01 NYSTATIN. 1 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NYADERM | 100000 UNIT | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716871 |
| CANDISTATIN TOPICAL POWDER - 100000 UNIT/G | 100000 UNIT | POWDER | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02195704 |
| MYCOSTATIN CRM 100000UNIT/GM | 100000 UNIT | CREAM | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 00029092 |
| MYCOSTATIN ONT 100000IU/GM | 100000 UNIT | OINTMENT | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 00029556 |
| MYCOSTATIN TOPICAL PWR 100,000UNITS/GM | 100000 UNIT | POWDER | CONVATEC, DIVISION OF BRISTOL-MYERS SQUIBB CANADA CO. | CANCELLED POST MARKET | DIN 02004674 |
| NADOSTINE CRM 100000IU/GM | 100000 UNIT | CREAM | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00288217 |
| NADOSTINE ONT 100000IU/GM | 100000 UNIT | OINTMENT | LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00288195 |
| NILSTAT TOP CRM 100000UNIT/GM | 100000 UNIT | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00449792 |
| NILSTAT TOP ONT 100000UNIT/GM | 100000 UNIT | OINTMENT | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00449806 |
| NYADERM ONT 100000UNIT/GM | 100000 UNIT | OINTMENT | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 00716898 |
Who else supplies NYSTATIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NYSTATIN appears in 1378 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does NYSTATIN cost around the world?
NYSTATIN is listed on 9 national price registers Nexara tracks, across 101 pack listings published on 8 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 5 | 47 | 03 Sep 2026 |
| Saudi Arabia | public | 14 | 18 | 01 Sep 2026 |
| South Africa | single exit price | 8 | 11 | 01 Sep 2026 |
| Australia | ex-manufacturer | 4 | 8 | 08 Sep 2026 |
| Romania | max producer price | 2 | 5 | 03 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 5 | 5 | 03 Sep 2026 |
| Bahrain | retail (max) | 2 | 3 | 01 Sep 2026 |
| United Arab Emirates | public | 2 | 2 | 31 Aug 2026 |
| Norway | max AUP (pharmacy retail) | 2 | 2 | 07 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.